Ciprozid .


Ciprozid .


Stock Status:

In Stock

  • *Upload Prescription

    • (max file size 80 MB)


Indications of Ciprozid Ophthalmic Solution

Ciprofloxacin 0.3% Eye / revealed that for the treatment of infections caused by the conditions set under ear drops with sensitive strains of designated microorganisms:

Horny ulcers: Pseudomonas Aeruginosa, Serratia Marcescens, Staphylococcus aureus, Staphylococcus epidermidis, Staphyrococus pneumoniae.

Conjunctivitis bacteria: Haemophilus influenza, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae. In addition, potassium salt, keratoponium salt, neuritis, bilepuronus, the prevention of dacryocistite or eye surgery, after anti-infection of a corneal infection due to the salt of meat and the Chlamydia trachomatis, it has also been demonstrated in the treatment of the prevention of ocular infection.

EAR: OTITI EXTERNA, acute oil, chronic chest pyline. Prevention of annoying surgery such as reclining surgery.


Pharmacology of Ciprozid Ophthalmic Solution

Ciprofloxacin is a synthetic broad-spectrum antibacterial agent for intravenous administration. The bactericidal action of ciprofloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair and recombination.


Dosage & Administration of Ciprozid Ophthalmic Solution

Corneal ulcers: The recommended dosage regimen for the treatment of corneal ulcers is two drops into the affected eye every 15 minutes for the first 6 hours and then two drops into the affected eye every 30 minutes for the remainder of the first day. On the second day, instill 2 drops in the affected eye hourly. On the third through the fourteenth day, place two drops in the affected eye every four hours. Treatment may be continued after 14 days if corneal re-epithelization has not been occurred.

Bacterial conjunctivitis: The recommended dosage regimen for the treatment of bacterial conjunctivitis is one or two drops instilled into the conjunctival sac(s) every two hours while awake for two days and one or two drops every four hours while awake for the next five days.

Ear infections: For all infections, 2-3 drops every 2-3 hours initially, reducing the frequency of the instillation with control of infection. Treatment should be continued at least 7 days.



Allergic to quinolone antibacterial drugs or any ingredient in the formulation.


Side Effects of Ciprozid Ophthalmic Solution

Local burning or discomfort, itching, foreign body sensation, precipitation of crystals, marginal crusts, conjunctival congestion and unpleasant taste after administration. Phobias and nausea can be reported.


Pregnancy & Lactation

Do not use unless the potential benefit outweighs the possible risk during pregnancy. It is not known whether excretion into breast milk occurs after topical eye drops. Caution is recommended in nursing mothers.


Precautions & Warnings

Long-term ocular use of ciprofloxacin may cause an overgrowth of insensitive microorganisms (including fungi). Ciprofloxacin should be discontinued at the first appearance of a rash or any other sign of hypersensitivity.


Therapeutic Class

Aural Anti-bacterial preparations, Ophthalmic antibacterial drugs


Storage Conditions

Store below 30°C in a cool, dry place, protected from light. Keep out of reach of CHILDREN. Do not touch the dropper tip to surfaces as this may contaminate the solution. Do not use after 30 days from the date of first opening the box.


Pharmaceutical Name of Ciprozid Ophthalmic Solution

Drug International Ltd


Generic of Ciprozid Ophthalmic Solution